Candel Therapeutics, Inc. (NASDAQ:CADL) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joseph Papa Other companies: Milestone Pharmaceuticals Inc. (Independent Non-Executive Director · Since at least Sep 3, 2024); Emergent BioSolutions Inc. (President and Chief Executive Officer · Since at least Feb 21, 2024); Bausch + Lomb Corporation (See Remarks, Director · May 5, 2022 – May 5, 2022 · Past); Prometheus Biosciences Inc (Director · Mar 11, 2021 – Jun 16, 2023 · Past); Bausch Health Companies Inc. (Director · May 2, 2016 – May 10, 2022 · Past); Perrigo Company plc (Director · Oct 9, 2006 – Feb 26, 2016 · Past) | Chairman · Since at least Aug 8, 2022 |
| Paul B. Manning Other companies: Liquidia Corporation (Board Member · Since at least Nov 18, 2020); Verrica Pharmaceuticals Inc. (Chairman · Since at least Jun 14, 2018); Taysha Gene Therapies, Inc. (Director · Sep 23, 2020 – Oct 31, 2022 · Past); Dova Pharmaceuticals Inc (Director · Jun 28, 2017 – Nov 12, 2019 · Past); AveXis Inc (Director · Feb 10, 2016 – Feb 10, 2016 · Past); Perrigo Company plc (EVP & General Manager, PBM · Jun 9, 2010 – Jun 9, 2010 · Past) | Chair of the Board · Since at least Jul 26, 2021 |
| Renee Gaeta Other companies: Outset Medical, Inc. (Chief Financial Officer · Since at least Jun 3, 2025); Shockwave Medical Inc (Chief Financial Officer · Feb 5, 2024 – May 31, 2024 · Past); SeaSpine Holdings Corp (Director · Feb 19, 2019 – Jan 5, 2023 · Past); Establishment Labs Holdings Inc. (Chief Financial Officer · Jul 18, 2018 – May 20, 2021 · Past) | Director · Since at least Aug 8, 2022 |
| Jason Amello Other companies: TScan Therapeutics, Inc. (Chief Financial Officer · Since at least Jan 29, 2024); Acer Therapeutics Inc (Director · Jan 2, 2020 – Mar 14, 2023 · Past); Akebia Therapeutics, Inc. (SVP, CFO & Treasurer · Apr 11, 2019 – Feb 28, 2020 · Past) | Chief Financial Officer · Sep 21, 2022 – Nov 28, 2023 · Past |
| Diem Nguyen Other companies: SIGA Technologies Inc. (Chief Executive Officer, Director · Since at least Jan 27, 2024); Verrica Pharmaceuticals Inc. (Director · Since at least Jun 9, 2020) | Director · Since at least Jul 26, 2021 |
| Gary J. Nabel Other companies: OPKO Health, Inc. (President and CEO of ModeX Therapeutics, Chief Innovation Officer · Since at least May 9, 2022); SIGA Technologies Inc. (Director · Since at least Jun 15, 2021) | President · Since at least Aug 8, 2022 |
| Maha Radhakrishnan Other companies: Entrada Therapeutics, Inc. (Industry Leader and Independent Director · Since at least Jun 1, 2025); Alto Neuroscience, Inc. (Director · Mar 8, 2024 – Mar 8, 2024 · Past) | Director · Since at least Jun 4, 2025 |
| Edward J Benz Jr Other companies: Deciphera Pharmaceuticals LLC (Director · Jun 11, 2024 – Jun 11, 2024 · Past) | Director · Since at least Jun 26, 2024 |
| John J Canepa Other companies: Harvard Apparatus Regenerative Technology Inc (Director · Oct 16, 2013 – Mar 14, 2018 · Past) | Chief Financial Officer · Jul 26, 2021 – Feb 28, 2022 · Past |
| Martine Zimmermann Other companies: Ligand Pharmaceuticals Incorporated (Director · Since at least Sep 22, 2023) | Director · Since at least Sep 8, 2026 |
| Shaan-Chirag C Gandhi Other companies: Vigil Neuroscience Inc (Director · Jan 6, 2022 – Jan 6, 2022 · Past) | Director · Jul 26, 2021 – Jul 26, 2021 · Past |
| W. Garrett Nichols Other companies: Chimerix Inc (Chief Medical Officer · Sep 2, 2014 – Feb 7, 2020 · Past) | Chief Medical Officer · Since at least Sep 12, 2022 |
| Charles Schoch | Chief Financial Officer · Since at least Jan 12, 2024 |
| Christopher Martell | Director · Since at least Jul 26, 2021 |
| Edward J. Benz | President · Since at least Nov 5, 2026 |
| Elizabeth Jaffee | Deputy Director · Since at least Mar 18, 2025 |
| Francesca Barone | Chief Scientific Officer · Since at least Feb 3, 2022 |
| Henry Brem | Director, Department of Neurosurgery · Since at least Nov 17, 2025 |
| James P. Allison | Chief of the Department of Immunology · Since at least Nov 17, 2025 |
| Laura K Aguilar | Chief Medical Officer · Jul 26, 2021 – Jul 29, 2021 · Past |
| Maria Ostrovsky | General Counsel · Since at least Oct 22, 2026 |
| Mark Sims | Chief Commercial Officer · Since at least Jul 6, 2026 |
| Nicoletta Loggia | Director · Since at least Jun 7, 2023 |
| Paul Peter Tak | President & Chief Executive Officer · Since at least Jul 26, 2021 |
| Philip Kantoff | Co-Founder, Convergent Therapeutics · Since at least Nov 17, 2025 |
| Roy Herbst | Director, Dartmouth Cancer Center · Since at least Jul 1, 2026 |
| Seshu Tyagarajan | Chief Technology Officer · Since at least Nov 17, 2025 |
| Susan Stewart | Chief Regulatory Officer · Since at least Nov 5, 2026 |
| Theodore Jenkins | Vice President · Since at least Jul 9, 2026 |
| Udi Meirav | Director · Jul 26, 2021 – Jul 26, 2021 · Past |